← Back
$KRYS All transactions

Krystal Biotech, Inc.

F

$ Value

$502K

Shares

1,820

Price

$276

Filed

Mar 3

Insider

Name

Krishnan Krish S

Title

President and CEO

CIK

0001298709

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2026-02-27

Code

F

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,428,155

Footnotes

35,000 restricted stock units ("RSUs") were granted on February 29, 2024. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period. 8,750 RSUs vested on February 27, 2026. | Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 8,750 RSUs on February 27, 2026. | The closing price on February 27, 2026 of the Company's common stock on the Nasdaq Global Select Market. | 52,500 performance stock units ("PSUs") were granted on February 29, 2024. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and the remaining one-half of the PSUs granted, or 26,250 PSUs, vested on February 27, 2026. | Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 26,250 PSUs on February 27, 2026. | 22,900 restricted stock units ("RSUs") were granted on February 28, 2025. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period with the first installment, or 5,725 RSUs, vesting on February 27, 2026. | Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 5,725 RSUs on February 27, 2026. | 45,000 performance stock units ("PSUs") were granted on February 29, 2024, to the Reporting Person's spouse, Suma M. Krishnan. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31, 2024, as approved by the Company's Compensation Committee, and the Reporting Person's spouse continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and the remaining one-half of the PSUs granted, or 22,500 PSUs, vested on February 27, 2026. | These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan. | Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person. | Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 22,500 PSUs on February 27, 2026. | 16,000 restricted stock units ("RSUs") were granted on February 28, 2025 to the Reporting Person's spouse, Suma M. Krishnan. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's spouse continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period with the first installment, or 4,000 RSUs, vesting on February 27, 2026. | Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Suma M. Krishnan, upon the vesting of 4,000 RSUs on February 27, 2026. | Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control. | The stock options vests in four equal annual installments beginning on February 27, 2027. | Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. | The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable vesting dates. | The RSUs vest in four equal annual installments with the first installment vesting on February 27, 2027.

Filing Info

Accession No.

0001298709-26-000002

Form Type

4

Issuer CIK

0001711279

Krishnan Krish S's History

Date Ticker Type Value
2026-03-04 KRYS $124K
2026-03-04 KRYS $121K
2026-03-04 KRYS $358K
2026-03-04 KRYS $815K
2026-03-04 KRYS $774K
2026-03-04 KRYS $625K
2026-03-04 KRYS $539K
2026-03-04 KRYS $2.3M
2026-03-04 KRYS $648K
2026-03-04 KRYS $245K

Other Insiders at KRYS (90d)

Insider Bought Sold Last
JANNEY DANIEL $19.4M 2026-02-27
ROSSI DINO A $5.0M 2026-02-19
Krishnan Krish S
President and CEO
$6.6M 2026-03-04
Krishnan Suma
President, R&D
$6.6M 2026-03-04
ROMANO KATHRYN
Chief Accounting Officer
$3.6M 2026-03-02